Media Mention August 24, 2018

BYLINE: Time To Remove Patent Barriers To US Drug Manufacturing (Law360)

Partner Fred Rein and associates Aviv Zalcenstein and Ilana Saltz discuss why the United States should consider amending its patent laws to permit both the export and stockpiling of pharmaceuticals during the patent term extension (PTE) period.

Read the full article.